Citation: | WANG Yuzhen, JIAO Lihua, KANG Guo, LI Shuhua, ZHANG Shuang. Effect of phenobarbital combined with sodium valproate for patients with reversible splenial lesion syndrome[J]. Journal of Clinical Medicine in Practice, 2022, 26(11): 48-52. DOI: 10.7619/jcmp.20214584 |
To observe the effect of phenobarbital combined with sodium valproate and their effects on cysteine aspartate protease-3 (caspase-3) and myelin basic protein (MBP) in patients with reversible splenial lesion syndrome (RESLES).
A total of 60 patients with RESLES were selected as study objects, and were randomly divided into study group (30 cases) and control group(30 cases). Both groups received conventional treatment. The patients in the control group orally administered sodium valproate sustained-release tablets, and those in the study group received oral phenobarbital combined with sodium valproate sustained-release tablets for 3 weeks.The expressions of caspase-3, MBP, oxidative stress, the indicators of inflammatory factors were tested, and the number of attacks before and after treatment, Hospital Anxiety and Depression Scale (HAD) score, Montreal Cognitive Assessment Scale (MoCA) score, efficacy of treatment after treatment and the incidence of total adverse reactions were compared in the two groups.
After treatment, caspase-3, MBP, superoxide dismutase (SOD), catalase (CAT), interleukin-2 (IL-2), tumor necrosis factor -α (TNF-α) and interferon-γ (IFN-γ) levels of the two groups were significantly lower than before treatment, and MDA was higher than before treatment(P < 0.05). After treatment, caspase-3, MBP, SOD, CAT and IL-2, TNF-α, IFN-γ in the study group were lower than those in the control group, and malondialdehyde (MDA) was higher than the control group (P < 0.05). After treatment, the levels of caspase-3, MBP, SOD, CAT, IL-2, TNF-α and IFN-γ in the study group were lower, while MDA level was higher than that in the control group (P < 0.05). After treatment, the number of attacks in the study group was less, HAD score was lower, and the MoCA score was higher than that in the control group (P < 0.05). The total effective rate in the study group was higher than that in the control group (P < 0.05). There was no significant difference in the incidence of total adverse reactions between two groups (P>0.05).
The treatment of phenobarbital combined with sodium valproate can effectively improve the levels of caspase-3 and MBP for RESLES patients, relieve inflammation and oxidative stress, and improve cognitive function. Therefore, their combination has better clinical effect.
[1] |
GE Y X, LIN Y Y, BI Q Q, et al. Reversible splenial lesion syndrome (RESLES) after chemotherapy of oral tegafur-uracil in a female with locally rectal adenocarcinoma[J]. Cogn Behav Neurol, 2020, 33(4): 283-287. doi: 10.1097/WNN.0000000000000250
|
[2] |
GUO K D, LAI X H, LIU Y, et al. Anti-glial fibrillary acidic protein antibodies as a cause of reversible splenial lesion syndrome (RESLES): a case report[J]. Neurol Sci, 2021, 42(9): 3903-3907. doi: 10.1007/s10072-021-05376-y
|
[3] |
LU P L, HODES J F, ZHENG X, et al. Reversible splenial lesion syndrome with some novel causes and clinical manifestations[J]. Intern Med, 2020, 59(20): 2471-2480. doi: 10.2169/internalmedicine.4516-20
|
[4] |
陈丹丹, 董莹. 天麻钩藤汤联合丙戊酸钠治疗脑卒中后继发性癫痫的疗效[J]. 中国老年学杂志, 2021, 41(9): 1869-1871. doi: 10.3969/j.issn.1005-9202.2021.09.025
|
[5] |
李小玉, 章鹏, 何小庆. 左乙拉西坦联合苯巴比妥和卡马西平治疗难治性部分性癫痫临床研究[J]. 医学临床研究, 2020, 37(6): 943-946.
|
[6] |
刘春艳, 柴艺汇, 田兴中, 等. 天麻破壁粉、冻干粉对戊四唑诱导癫痫大鼠海马组织Bcl-2、Bax、Caspase-3、GAT-1mRNA及蛋白表达对比研究[J]. 世界科学技术-中医药现代化, 2020, 22(1): 147-156. https://www.cnki.com.cn/Article/CJFDTOTAL-SJKX202001025.htm
|
[7] |
董晗, 王智昊, 王哲, 等. 微小RNA-124调控APLN表达在癫痫神经元损伤中的作用及机制研究[J]. 中风与神经疾病杂志, 2021, 38(3): 237-241. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFSJ202103010.htm
|
[8] |
贾东佩, 李春雷. 穴位埋线治疗难治性癫痫疗效及对血清GAL、PGP、MBP的影响[J]. 陕西中医, 2019, 40(4): 528-530. doi: 10.3969/j.issn.1000-7369.2019.04.038
|
[9] |
TANG Y, ZHANG D, GE J, et al. Clinical and imaging features of reversible splenial lesion syndrome with language disorder[J]. Transl Neurosci, 2020, 11(1): 210-214. doi: 10.1515/tnsci-2020-0126
|
[10] |
闫新成, 徐朝霞, 郭苏晋, 等. 可逆性胼胝体压部病变综合征MRI表现[J]. 临床医学研究与实践, 2021, 6(12): 4-6, 9. https://www.cnki.com.cn/Article/CJFDTOTAL-YLYS202112003.htm
|
[11] |
高茜, 赵红霞, 李忠春, 等. 微核糖核酸-221对小鼠癫痫神经元细胞的作用及其机制研究[J]. 上海医学, 2021, 44(2): 104-108. https://www.cnki.com.cn/Article/CJFDTOTAL-SHYX202102009.htm
|
[12] |
赵秀英, 符之富, 阙利双, 等. 血浆miR-106b、miR-146a表达水平与癫痫患儿脑电图参数、Th17细胞和凋亡分子的相关性分析[J]. 现代生物医学进展, 2021, 21(17): 3378-3382. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202117038.htm
|
[13] |
崔海珍, 王华. 丙戊酸钠致高氨血症脑病和癫痫加重1例[J]. 中国药物应用与监测, 2021, 18(3): 204-206. doi: 10.3969/j.issn.1672-8157.2021.03.017
|
[14] |
荆竹山, 邱迎军. 左乙拉西坦治疗癫痫患儿的疗效及对患儿血清细胞因子GFAP和MBP水平的影响[J]. 中国药物与临床, 2020, 20(17): 2878-2880. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC202017024.htm
|
[15] |
陈星, 倪莹莹. 自拟利水方合穴位针刺治疗外伤后继发脑积水疗效及对血清MBP、S100β、NSE水平的影响[J]. 现代中西医结合杂志, 2019, 28(36): 4039-4042. doi: 10.3969/j.issn.1008-8849.2019.36.012
|
[16] |
王翀, 朱晓蕾, 王晓云. 丙戊酸钠联合左乙拉西坦或拉莫三嗪治疗癫痫对脑电图的影响[J]. 河北医学, 2021, 27(3): 516-521. doi: 10.3969/j.issn.1006-6233.2021.03.035
|
[17] |
李琼, 葛娜, 张菲菲, 等. 咪达唑仑联合苯巴比妥、地西泮治疗小儿惊厥性癫痫持续状态的临床研究[J]. 临床误诊误治, 2019, 32(9): 31-34. doi: 10.3969/j.issn.1002-3429.2019.09.009
|
[18] |
钱悠悠. 拉莫三嗪联合小剂量丙戊酸钠治疗初诊癫痫的疗效及对神经认知功能的影响[J]. 实用临床医药杂志, 2020, 24(2): 80-82, 86. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202002024.htm
|
[19] |
廖良华, 岑贞颐, 黄月艳. 惊厥性癫痫持续状态患儿相关指标及头颅磁共振成像价值的研究进展[J]. 实用临床医药杂志, 2021, 25(1): 109-112. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202101028.htm
|
[20] |
吴海威, 张娜. 左乙拉西坦联合丙戊酸钠治疗癫痫的效果及对脑损伤标志物和炎性因子的影响[J]. 河北医药, 2021, 43(10): 1535-1537, 1541. doi: 10.3969/j.issn.1002-7386.2021.10.022
|
[21] |
陈春荣, 李顺斌. 苯巴比妥对小儿热性惊厥的治疗效果及复发惊厥的危险因素分析[J]. 中国妇幼保健, 2019, 34(13): 3009-3012. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201913034.htm
|